Talk about getting ahead of yourself.
Last June, Celator Pharmaceuticals proudly displayed a large poster touting its experimental Vyxeos medication as an effective salve for treating acute myeloid leukemia. The poster was, in fact, one of countless placards featured prominently on the exhibit floor at the American Society of Clinical Oncology meeting in Chicago, a sort of Woodstock for cancer doctors and eager investors.
Despite the numerous displays, however, the Celator poster managed to stick out.
About the Author Reprints
Who was the offical maker of the cure?
Hi Abigail
Celator.
ed
FDA got it right but for the wrong reason. The coequal infraction here is an implied claim of superiority, although FDA makes zero mention of this.